Fowler CJ |
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. |
2008 |
Curr. Pharm. Des. |
pmid:18781976
|
Ruby MA et al. |
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. |
2008 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18794527
|
DiPatrizio NV and Simansky KJ |
Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. |
2008 |
J. Neurosci. |
pmid:18815256
|
Bajo M et al. |
Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. |
2009 |
J. Neurosci. Res. |
pmid:18816788
|
Catani MV et al. |
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol. |
2009 |
J. Mol. Med. |
pmid:18820887
|
Ortar G et al. |
Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. |
2008 |
J. Med. Chem. |
pmid:18831576
|
Kreutz S et al. |
2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells. |
2009 |
Glia |
pmid:18837048
|
Garcia-Ovejero D et al. |
The endocannabinoid system is modulated in response to spinal cord injury in rats. |
2009 |
Neurobiol. Dis. |
pmid:18930143
|
Lu TS et al. |
Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. |
2008 |
J. Immunol. |
pmid:18941231
|
Di Marzo V et al. |
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. |
2009 |
Diabetologia |
pmid:18972095
|
Hill MN et al. |
Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. |
2008 |
J Neural Transm |
pmid:18974922
|
Bisogno T et al. |
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. |
2009 |
Biochim. Biophys. Acta |
pmid:19027877
|
Long JZ et al. |
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. |
2009 |
Nat. Chem. Biol. |
pmid:19029917
|
Vignali M et al. |
The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes. |
2009 |
Glia |
pmid:19031444
|
Lehtonen M et al. |
Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. |
2008 |
Chem. Biodivers. |
pmid:19035572
|
Marinelli S et al. |
The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. |
2008 |
J. Neurosci. |
pmid:19074027
|
Jiang LS et al. |
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. |
2009 |
Cardiovasc. Res. |
pmid:19074161
|
Wang J and Ueda N |
Biology of endocannabinoid synthesis system. |
2009 |
Prostaglandins Other Lipid Mediat. |
pmid:19126434
|
Koppel J et al. |
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study. |
2009 |
Lipids Health Dis |
pmid:19144193
|
Schlosburg JE et al. |
Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. |
2009 |
AAPS J |
pmid:19184452
|